The inoculation campaign is expected to lower the mortality rate in children, as malaria makes up 19 percent of child deaths ...

This week, the FDA approved Eli Lilly’s LLY eczema drug, Ebglyss (lebrikizumab), and the expanded use of Novartis’ NVS ...

IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.

(Reuters) -The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for ...

GSK PLC GSK shares slipped 2.45% to £15.36 Friday, on what proved to be an all-around grim trading session for the stock ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

The Atlanta-based beverage maker’s investment will support businesses in the value chain including distributors, retailers ...

Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

Neuberg Diagnostics unveils 'Geniee', a personalised genomics platform offering genetic testing and tailored medicine for ...

Data science is one of the most current career choices today, especially in a data-driven world. Today, more businesses rely on data for making strategic decisi ...

Until recently, the pharmaceutical industry remained relatively insulated from the simmering trade war between China and the ...

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...